Serological testing for assessing individuals’ adaptive immune responses
Exclusive interview with infectious diseases expert on the development of new assays including those for SARS-CoV-2
Exclusive interview with infectious diseases expert on the development of new assays including those for SARS-CoV-2
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens
Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel
Find out how Zymo Research’s state-of-the-art tools are helping laboratories and government agencies facilitate large-scale COVID-19 testing in the United States
Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients
Join us on Tuesday, November 3, to find out how significant gains in both speed and sensitivity can be achieved in well-designed NOAH (NMR by ordered acquisition using 1H detection) supersequences.
Watch this webinar on demand to learn about the host immune response to COVID-19
The Leo Foundation-funded study for first time identifies Sbi as the molecule that induces rapid release of Interleukin-33
Novel column technology designed to put disease research and drug development on a more productive and efficient path
Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry
The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C
The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses